Rifampicin at High Dose for Difficult-to-Treat Tuberculosis

Condition:   Tuberculosis Intervention:   Drug: Rifampin Sponsors:   Hospital Universitari Vall d'Hebron Research Institute;   University Medical Center Groningen;   Radboud University;   Centro Hospitalar De São João, E.P.E.;   Instituto Nacional de Enfermedades Respiratorias y del Ambiente, Paraguay Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials